Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences, Genomenon to Co-Market NGS Panel Design Service

NEW YORK (GenomeWeb) – Swift Biosciences and Genomenon said today that they have entered a new partnership in which they will co-market a service for the design and creation of targeted gene sequencing panels.

In the companies' new combined service, Genomenon will use its automated machine learning approach and Mastermind Genomic Search Engine to identify biomarker targets associated with diseases, producing a list of candidate biomarkers. It will then curate these biomarkers based on the strength and quality of the scientific evidence found in the literature, delivering a final prioritized set.

Swift's role is then to build and validate Accel-Amplicon Custom NGS Panels for the targets in question. The company's technology combines a two-hour, single-tube workflow with highly multiplexed, targeted PCR libraries that are compatible with both Illumina and Ion Torrent sequencing platforms, as well as with most sample types, including limited or degraded samples such as FFPE and cell-free DNA.

Financial and other details of the collaboration were not disclosed.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.